Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Margiani G, Castelli MP, Pintori N, Frau R, Ennas MG, Zottola ACP, Orrù V, Serra V, Fiorillo E, Fadda P, Marsicano G, De Luca MA. Correction to: Adolescent self‑administration of the synthetic cannabinoid receptor agonist JWH‑018 induces neurobiological and behavioral alterations in adult male mice. Psychopharmacology (Berl). 2023 May;240(5):1199. doi: 10.1007/s00213-023-06353-3. PubMed PMID: 36928987; PubMed Central PMCID: PMC10102038.
Giunti E, Collu R, Dedoni S, Castelli MP, Fratta W, Scherma M, Fadda P. Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats. Behav Brain Res. 2023 Apr 27;444:114374. doi: 10.1016/j.bbr.2023.114374. Epub 2023 Feb 28. PubMed PMID: 36863461.
Santoni M, Sagheddu C, Serra V, Mostallino R, Castelli MP, Pisano F, Scherma M, Fadda P, Muntoni AL, Zamberletti E, Rubino T, Melis M, Pistis M. Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. Brain Behav Immun. 2023 Mar;109:271-284. doi: 10.1016/j.bbi.2023.02.002. Epub 2023 Feb 4. PubMed PMID: 36746342.
Santoro M, Fadda P, Klephan KJ, Hull C, Teismann P, Platt B, Riedel G. Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's disease. J Neurochem. 2023 Jan;164(2):121-142. doi: 10.1111/jnc.15699. Epub 2022 Nov 9. PubMed PMID: 36184945; PubMed Central PMCID: PMC10098710.
Qvist JS, Scherma M, Jayaram-Lindström N, Fratta W, Kandel DB, Kandel ER, Fadda P, Melas PA. Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence. Int J Mol Sci. 2022 Dec 31;24(1). doi: 10.3390/ijms24010698. PubMed PMID: 36614142; PubMed Central PMCID: PMC9820805.
Manchia M, Isayeva U, Collu R, Primavera D, Deriu L, Caboni E, Iaselli MN, Sundas D, Tusconi M, Pinna F, Paribello P, Scherma M, Pisanu C, Meloni A, Zai CC, Congiu D, Squassina A, Fratta W, Fadda P, Carpiniello B. Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders. Brain Sci. 2022 Dec 4;12(12). doi: 10.3390/brainsci12121666. PubMed PMID: 36552127; PubMed Central PMCID: PMC9775399.
Isayeva U, Manchia M, Collu R, Primavera D, Deriu L, Caboni E, Iaselli N, Sundas D, Tusconi M, Pinna F, Paribello P, Scherma M, Pisanu C, Meloni A, Zai CC, Congiu D, Squassina A, Fratta W, Fadda P, Carpiniello B. Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients. Eur Psychiatry. 2022 Oct 25;65(1):e71. doi: 10.1192/j.eurpsy.2022.2333. PubMed PMID: 36281033; PubMed Central PMCID: PMC9677441.
Margiani G, Castelli MP, Pintori N, Frau R, Ennas MG, Pagano Zottola AC, Orrù V, Serra V, Fiorillo E, Fadda P, Marsicano G, De Luca MA. Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice. Psychopharmacology (Berl). 2022 Oct;239(10):3083-3102. doi: 10.1007/s00213-022-06191-9. Epub 2022 Aug 9. PubMed PMID: 35943523; PubMed Central PMCID: PMC9481487.
Palmas MF, Etzi M, Pisanu A, Camoglio C, Sagheddu C, Santoni M, Manchinu MF, Pala M, Fusco G, De Simone A, Picci L, Mulas G, Spiga S, Scherma M, Fadda P, Pistis M, Simola N, Carboni E, Carta AR. The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex. Cells. 2022 Aug 24;11(17). doi: 10.3390/cells11172628. PubMed PMID: 36078036; PubMed Central PMCID: PMC9454687.
Dedoni S, Avdoshina V, Camoglio C, Siddi C, Fratta W, Scherma M, Fadda P. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research. Molecules. 2022 Jun 28;27(13). doi: 10.3390/molecules27134142. Review. PubMed PMID: 35807384; PubMed Central PMCID: PMC9268291.
Cocco E, Fadda P. Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil. Exp Neurol. 2022 Jan;347:113906. doi: 10.1016/j.expneurol.2021.113906. Epub 2021 Oct 26. Review. PubMed PMID: 34710403.
Pintori N, Castelli MP, Miliano C, Simola N, Fadda P, Fattore L, Scherma M, Ennas MG, Mostallino R, Flore G, De Felice M, Sagheddu C, Pistis M, Di Chiara G, De Luca MA. Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates. Br J Pharmacol. 2021 Sep;178(17):3476-3497. doi: 10.1111/bph.15494. Epub 2021 Jun 29. PubMed PMID: 33837969; PubMed Central PMCID: PMC8457172.
Ghandour F, Squassina A, Karaky R, Diab-Assaf M, Fadda P, Pisanu C. Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review. Brain Sci. 2021 Feb 27;11(3). doi: 10.3390/brainsci11030301. Review. PubMed PMID: 33673559; PubMed Central PMCID: PMC7997443.
Melas PA, Scherma M, Fratta W, Cifani C, Fadda P. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research. Int J Mol Sci. 2021 Feb 13;22(4). doi: 10.3390/ijms22041863. Review. PubMed PMID: 33668469; PubMed Central PMCID: PMC7917759.
Fattore L, Fadda P, Zanda MT, Fratta W. Analysis of Opioid-Seeking Behavior Through the Intravenous Self-Administration Reinstatement Model in Rats. Methods Mol Biol. 2021;2201:231-245. doi: 10.1007/978-1-0716-0884-5_21. PubMed PMID: 32975804.
Scherma M, Fattore L, Fratta W, Fadda P. Conditioned Place Preference (CPP) in Rats: From Conditioning to Reinstatement Test. Methods Mol Biol. 2021;2201:221-229. doi: 10.1007/978-1-0716-0884-5_20. PubMed PMID: 32975803.
Boi L, Pisanu A, Palmas MF, Fusco G, Carboni E, Casu MA, Satta V, Scherma M, Janda E, Mocci I, Mulas G, Ena A, Spiga S, Fadda P, De Simone A, Carta AR. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers. Int J Mol Sci. 2020 Nov 12;21(22). doi: 10.3390/ijms21228535. PubMed PMID: 33198335; PubMed Central PMCID: PMC7696693.
Scherma M, Muntoni AL, Riedel G, Fratta W, Fadda P. Cannabinoids and their therapeutic applications in mental disorders
. Dialogues Clin Neurosci. 2020 Sep;22(3):271-279. doi: 10.31887/DCNS.2020.22.3/pfadda. Review. PubMed PMID: 33162770; PubMed Central PMCID: PMC7605020.
Scherma M, Qvist JS, Asok A, Huang SC, Masia P, Deidda M, Wei YB, Soni RK, Fratta W, Fadda P, Kandel ER, Kandel DB, Melas PA. Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine. Proc Natl Acad Sci U S A. 2020 May 5;117(18):9991-10002. doi: 10.1073/pnas.1920866117. Epub 2020 Apr 20. PubMed PMID: 32312805; PubMed Central PMCID: PMC7211986.
D'Addario C, Zaplatic E, Giunti E, Pucci M, Micioni Di Bonaventura MV, Scherma M, Dainese E, Maccarrone M, Nilsson IA, Cifani C, Fadda P. Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa. Int J Eat Disord. 2020 May;53(5):432-446. doi: 10.1002/eat.23271. Epub 2020 Apr 10. PubMed PMID: 32275093.
Collu R, Post JM, Scherma M, Giunti E, Fratta W, Lutz B, Fadda P, Bindila L. Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Apr;1865(4):158578. doi: 10.1016/j.bbalip.2019.158578. Epub 2019 Nov 26. PubMed PMID: 31778792.
Collu R, Scherma M, Piscitelli F, Giunti E, Satta V, Castelli MP, Verde R, Fratta W, Bisogno T, Fadda P. Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa. Int J Eat Disord. 2019 Nov;52(11):1251-1262. doi: 10.1002/eat.23157. Epub 2019 Aug 27. PubMed PMID: 31456239.
Scherma M, Giunti E, Fratta W, Fadda P. Gene knockout animal models of depression, anxiety and obsessive compulsive disorders. Psychiatr Genet. 2019 Oct;29(5):191-199. doi: 10.1097/YPG.0000000000000238. Review. PubMed PMID: 31464999.
Lecca S, Luchicchi A, Scherma M, Fadda P, Muntoni AL, Pistis M. Δ(9)-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation. Front Behav Neurosci. 2019;13:202. doi: 10.3389/fnbeh.2019.00202. eCollection 2019. PubMed PMID: 31551729; PubMed Central PMCID: PMC6743372.
Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G. Brain activity of anandamide: a rewarding bliss?. Acta Pharmacol Sin. 2019 Mar;40(3):309-323. doi: 10.1038/s41401-018-0075-x. Epub 2018 Jul 26. Review. PubMed PMID: 30050084; PubMed Central PMCID: PMC6460372.
Scherma M, Collu R, Satta V, Giunti E, Fadda P. Animal Models of Eating Disorders. Methods Mol Biol. 2019;2011:297-314. doi: 10.1007/978-1-4939-9554-7_17. Review. PubMed PMID: 31273706.
Sagheddu C, Scherma M, Congiu M, Fadda P, Carta G, Banni S, Wood JT, Makriyannis A, Malamas MS, Pistis M. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward. Neuropharmacology. 2019 Jan;144:327-336. doi: 10.1016/j.neuropharm.2018.11.013. Epub 2018 Nov 12. PubMed PMID: 30439418.
Scherma M, Masia P, Deidda M, Fratta W, Tanda G, Fadda P. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. Medicines (Basel). 2018 Oct 2;5(4). doi: 10.3390/medicines5040107. Review. PubMed PMID: 30279403; PubMed Central PMCID: PMC6313625.
Kononoff J, Melas PA, Kallupi M, de Guglielmo G, Kimbrough A, Scherma M, Fadda P, Kandel DB, Kandel ER, George O. Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood. Sci Rep. 2018 Sep 17;8(1):13893. doi: 10.1038/s41598-018-31921-5. PubMed PMID: 30224774; PubMed Central PMCID: PMC6141462.
Rosas M, Porru S, Giugliano V, Antinori S, Scheggi S, Fadda P, Fratta W, Acquas E, Fattore L. Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats. Behav Pharmacol. 2018 Sep;29(6):473-481. doi: 10.1097/FBP.0000000000000395. PubMed PMID: 29595540.
Melas PA, Qvist JS, Deidda M, Upreti C, Wei YB, Sanna F, Fratta W, Scherma M, Fadda P, Kandel DB, Kandel ER. Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats. Cell Rep. 2018 Mar 13;22(11):2909-2923. doi: 10.1016/j.celrep.2018.02.065. PubMed PMID: 29539420.
Frahm S, Melis V, Horsley D, Rickard JE, Riedel G, Fadda P, Scherma M, Harrington CR, Wischik CM, Theuring F, Schwab K. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease. Behav Brain Res. 2018 Feb 26;339:153-168. doi: 10.1016/j.bbr.2017.11.025. Epub 2017 Nov 24. PubMed PMID: 29180135.
Satta V, Scherma M, Piscitelli F, Usai P, Castelli MP, Bisogno T, Fratta W, Fadda P. Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats. Front Neurosci. 2018;12:40. doi: 10.3389/fnins.2018.00040. eCollection 2018. PubMed PMID: 29456490; PubMed Central PMCID: PMC5801427.
Zanda MT, Fadda P, Antinori S, Di Chio M, Fratta W, Chiamulera C, Fattore L. Methoxetamine affects brain processing involved in emotional response in rats. Br J Pharmacol. 2017 Oct;174(19):3333-3345. doi: 10.1111/bph.13952. Epub 2017 Aug 19. PubMed PMID: 28718892; PubMed Central PMCID: PMC5595753.
Scherma M, Satta V, Collu R, Boi MF, Usai P, Fratta W, Fadda P. Cannabinoid CB(1) /CB(2) receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia. Br J Pharmacol. 2017 Aug;174(16):2682-2695. doi: 10.1111/bph.13892. Epub 2017 Jul 11. PubMed PMID: 28561272; PubMed Central PMCID: PMC5522993.
Primavera D, Manchia M, Deriu L, Tusconi M, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study. BMJ Open. 2017 May 25;7(5):e014938. doi: 10.1136/bmjopen-2016-014938. PubMed PMID: 28550022; PubMed Central PMCID: PMC5729982.
Struik D, Fadda P, Zara T, Zamberletti E, Rubino T, Parolaro D, Fratta W, Fattore L. The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB(1) receptor density and function. Pharmacol Res. 2017 Jan;115:209-217. doi: 10.1016/j.phrs.2016.11.031. Epub 2016 Nov 24. PubMed PMID: 27890818.
Satta V, Scherma M, Giunti E, Collu R, Fattore L, Fratta W, Fadda P. Emotional profile of female rats showing binge eating behavior. Physiol Behav. 2016 Sep 1;163:136-143. doi: 10.1016/j.physbeh.2016.05.013. Epub 2016 May 11. PubMed PMID: 27180132.
Zanda MT, Fadda P, Chiamulera C, Fratta W, Fattore L. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings. Behav Pharmacol. 2016 Sep;27(6):489-96. doi: 10.1097/FBP.0000000000000241. Review. PubMed PMID: 27128862.
Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal Immune Activation Disrupts Dopamine System in the Offspring. Int J Neuropsychopharmacol. 2016 Jul;19(7). doi: 10.1093/ijnp/pyw007. Print 2016 Jul. PubMed PMID: 26819283; PubMed Central PMCID: PMC4966272.
Mutti A, Aroni S, Fadda P, Padovani L, Mancini L, Collu R, Muntoni AL, Fattore L, Chiamulera C. The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission. Psychopharmacology (Berl). 2016 Jun;233(12):2241-51. doi: 10.1007/s00213-016-4275-0. Epub 2016 Mar 28. PubMed PMID: 27020786.
Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology (Berl). 2016 May;233(10):1765-77. doi: 10.1007/s00213-015-4196-3. Epub 2016 Jan 4. Review. PubMed PMID: 26728894.
Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology. 2016 Apr;41(5):1416-26. doi: 10.1038/npp.2015.295. Epub 2015 Sep 21. PubMed PMID: 26388146; PubMed Central PMCID: PMC4793126.
Fattore L, Fadda P, Antinori S, Fratta W. Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview. Methods Mol Biol. 2015;1230:281-93. doi: 10.1007/978-1-4939-1708-2_24. Review. PubMed PMID: 25293335.
Serra V, Fattore L, Scherma M, Collu R, Spano MS, Fratta W, Fadda P. Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. Psychopharmacology (Berl). 2015 Jan;232(1):91-100. doi: 10.1007/s00213-014-3641-z. Epub 2014 Jun 13. PubMed PMID: 24923984.
Fattore L, Fadda P, Zanda MT, Fratta W. Analysis of opioid-seeking reinstatement in the rat. Methods Mol Biol. 2015;1230:295-307. doi: 10.1007/978-1-4939-1708-2_25. PubMed PMID: 25293336.
Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Front Neuroendocrinol. 2014 Aug;35(3):272-84. doi: 10.1016/j.yfrne.2014.04.003. Epub 2014 Apr 21. Review. PubMed PMID: 24769267.
Castelli MP, Madeddu C, Casti A, Casu A, Casti P, Scherma M, Fattore L, Fadda P, Ennas MG. Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. PLoS One. 2014;9(5):e98079. doi: 10.1371/journal.pone.0098079. eCollection 2014. PubMed PMID: 24844285; PubMed Central PMCID: PMC4028295.
Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, Dusek L, Fadda P, Micale V, Sulcova A, Fratta W, Fattore L. Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Front Pharmacol. 2014;5:44. doi: 10.3389/fphar.2014.00044. eCollection 2014. PubMed PMID: 24688470; PubMed Central PMCID: PMC3960502.
Scherma M, Fattore L, Castelli MP, Fratta W, Fadda P. The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence. Curr Pharm Des. 2014;20(13):2089-99. doi: 10.2174/13816128113199990429. Epub 2013 Jul 9. Review. PubMed PMID: 23829365.
What would you like to do?